Ticagrelor Versus Clopidogrel in Carotid Artery Stenting

PHASE2CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

April 28, 2022

Study Completion Date

April 28, 2022

Conditions
Carotid Artery Stenosis
Interventions
DRUG

Ticagrelor

DRUG

Clopidogrel

DRUG

Aspirin

Trial Locations (15)

1105

AMC Medical Research BV on behalf of Academisch Medisch Centrum, Amsterdam

3010

Insel Gruppe AG, Department of Neurology, Bern

3584

University Medical Center Utrecht, Utrecht

4031

University Hospital Basel, Basel

5001

Kantonsspital Aarau Klinik für Neurologie, Aarau

8063

Stadtspital Triemli Zürich/Department of Cardiology, Zurich

8500

AZ Groeninge VZW, Kortrijk

9000

Ghent University Hospital - Dept thoracic and vascular surgery, Ghent

20099

Asklepios Kliniken Hamburg GmbH, Hamburg

24105

Universitätsklinikum Schleswig-Holstein, Kiel

30035

Ospedale Civile di Mirano, Department of Cardiology, Mirano

30174

UOC Neuroradiologia, Ospedale dell'Angelo, Venezia

52074

University Hospital Aachen, Klinik für Diagnostische und Interventionelle Neuroradiologie, Aachen

69120

Universitätsklinikum Heidelberg, Neurologische Klinik, Heidelberg

S57AU

Sheffield Clinical Research Facility, Northern General Hospital, Sheffield

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT02677545 - Ticagrelor Versus Clopidogrel in Carotid Artery Stenting | Biotech Hunter | Biotech Hunter